We constructed a NAFLD-HCC mouse model to systematically assess the impact of APs-CS/PT-NPs on GM structure, acetate production, GPR43 signaling, and NF-κB-mediated inflammatory responses. The gene discussed is FFAR2; the disease is metabolic dysfunction-associated steatotic liver disease.